Clincosm LogoSign in Get a demo

carcinoma

Showing 26 - 50 of 189
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)

Recruiting
  • Carcinoma
  • Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
  • Los Angeles, California
  • +2 more
Nov 23, 2022

Lenvatinib in Combination With Pembrolizumab in Korean Patients

Recruiting
  • Endometrial Neoplasms
  • +2 more
  • Non-interventional
  • Ilsan, Gyeongji-do, Korea, Republic of
  • +14 more
Nov 21, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Carcinoma Trial in United States

Recruiting
  • Carcinoma
    • Orlando, Florida
    • +5 more
    Oct 27, 2022

    Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Advanced

    Completed
    • Carcinoma
    • no intervention
    • Jinan, Shandong, China
      Qilu Hospital, Shandong University
    Oct 23, 2022

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

    Completed
    Has Results
    • Solid Tumor
    • +4 more
    • Mogamulizumab + Nivolumab
    • Gilbert, Arizona
    • +14 more
    Jul 27, 2022

    Malignant Fluid Cells as a Biomarker for Rapid Therapy Guidance

    Recruiting
    • Pleural Effusion, Malignant
    • +2 more
      • Oakland, California
        xCures
      Aug 15, 2022

      Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

      Not yet recruiting
      • Carcinoma
      • +6 more
      • Anlotinib hydrochloride capsule
      • +2 more
      • (no location specified)
      Aug 8, 2022

      Malignant Tumor, Surgical Procedure, Unspecified, Health Care Provider Trial in United States (Best Practice, Informational

      Recruiting
      • Malignant Neoplasm
      • +3 more
      • Best Practice
      • +3 more
      • Newark, Delaware
      • +43 more
      Aug 2, 2022

      Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)

      Not yet recruiting
      • Carcinoma
      • Non-Small-Cell Lung
      • Orange City, Florida
      • +78 more
      Jul 20, 2022

      Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

      Recruiting
      • Basal Cell Carcinoma
      • +10 more
      • Nijmegen, Gelderland, Netherlands
      • +7 more
      Jul 14, 2022

      Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

      Completed
      • Carcinoma
      • +12 more
      • Ocoxin-Viusid
      • Havana, Cuba
        National Institute of Oncology and Radiobiology (INOR)
      Jul 5, 2022

      Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)

      Recruiting
      • Carcinoma
      • +4 more
      • Glizigen® + Ocoxin-Viusid®
      • Havana, Cuba
        Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
      Jul 5, 2022

      Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

      Recruiting
      • Pediatric Solid Tumor
      • +15 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jun 30, 2022

      Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

      Recruiting
      • Lung Neoplasm
      • +26 more
      • Boston, Massachusetts
      • +6 more
      Jun 23, 2022

      Tumors, Carcinoma Trial in United States (Financial Navigation)

      Recruiting
      • Neoplasms
      • Carcinoma
      • Financial Navigation
      • Charlotte, North Carolina
      • +8 more
      Jun 15, 2022

      Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)

      Recruiting
      • Metastatic Cancer
      • +2 more
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      May 11, 2022

      Carcinoma, Non-Small-Cell Lung Trial in Beijing (HLX10, an engineered anti-PD-1 antibody, HLX04, a bevacizumab biosimilar,

      Recruiting
      • Carcinoma
      • Non-Small-Cell Lung
      • HLX10, an engineered anti-PD-1 antibody
      • +3 more
      • Beijing, Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences (CAMS)
      Apr 29, 2022

      Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

      Recruiting
      • Pediatric Solid Tumor
      • +15 more
      • second generation 4-1BBζ EGFR806-EGFRt
      • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
      • Seattle, Washington
        Seattle Children's Hospital
      May 2, 2022

      Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

      Recruiting
      • Lung Neoplasm Malignant
      • +18 more
      • Fairfax, Virginia
        New Experimental Therapeutics of Virginia (NEXT Oncology)
      Mar 29, 2022

      Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

      Recruiting
      • Cancer
      • +7 more
      • ST-067
      • Scottsdale, Arizona
      • +3 more
      Mar 21, 2022

      Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)

      Recruiting
      • Solid Tumor
      • +3 more
      • Hong Kong, Hong Kong
        Hong Kong Children's Hospital
      Mar 14, 2022

      Overall Survival in Unresectable Hepatocellular Carcinoma

      Completed
      • Carcinoma, Hepatocellular
      • +3 more
      • Osaka, Japan
      • +1 more
      Mar 7, 2022

      Pancreatic Cancer, Carcinoma Trial in France (Gemcitabine, Folinic Acid, 5-Fluoro-uracil)

      Active, not recruiting
      • Pancreatic Cancer
      • Carcinoma
      • Aix-en-Provence, France
      • +44 more
      Mar 1, 2022